Edit

LENZ Therapeutics

https://lenz-tx.com/

Last activity: 07.03.2023

Active

Categories: ScienceInvestmentMedtechProduct

LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision. Our lead program is an aceclidine based eye drop designed to restore the loss of near vision associated with presbyopia. Presbyopia impacts almost two billion people globally and more than 120 million people in the US. LENZ Therapeutics is headquartered in San Diego, California, and is backed by multiple blue-chip venture capital investors.

Followers

428

Mentions

Location: United States, California, Solana Beach

Employees: 1-10

Total raised: $130.5M

Twitter

Investors 2

Date	Name	Website
-	RA Capital...	racap.com
14.03.2023	Alpha Wave...	alphawaveg...

Funding Rounds 2

Date	Series	Amount	Investors
07.03.2023	Series B	$83.5M	-
14.08.2021	Series A	$47M	-

Mentions in press and media 88

Date	Title	Description
07.03.2023	LENZ Therapeutics Finds $83.5M In Series B	San Diego-based biopharmaceuticals company LENZ Therapeutics, which is developing treatments for presbyopia, says it has raised $83.5M in a Series B financing round. The company said the funding was led by Sectoral Asset Management, and als...
07.03.2023	LENZ Therapeutics garners $83.5M in funding to support the registration and approval of their LNZ100/101 drug	-
21.04.2022	Orasis will ship its Vuity eye drop competitor to the FDA later this year with two PhIII wins	Orasis Pharmaceuticals probably doesn’t think it’s the underdog with the two Phase III results it has in hand for an eye drop meant to help people with age-related loss of near vision. But once the Florida biotech ships the e...
14.10.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
13.10.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
11.10.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
10.10.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
09.10.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
08.10.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
07.10.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
03.10.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
02.10.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
29.09.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
26.09.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
23.09.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
22.09.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
21.09.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
20.09.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
19.09.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
18.09.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
17.09.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
14.09.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
09.09.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
08.09.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
07.09.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
06.09.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
05.09.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
04.09.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
03.09.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
01.09.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
28.08.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
27.08.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
26.08.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
25.08.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
23.08.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
22.08.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
20.08.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
18.08.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
17.08.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
16.08.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
14.08.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
12.08.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
11.08.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
10.08.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
09.08.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
08.08.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
07.08.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
05.08.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
03.08.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
02.08.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
31.07.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
30.07.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
29.07.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
28.07.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
27.07.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
25.07.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
24.07.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
23.07.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
22.07.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
20.07.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
19.07.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
18.07.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
17.07.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
13.07.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
12.07.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
11.07.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
10.07.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
09.07.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
08.07.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
07.07.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
06.07.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
04.07.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
03.07.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
02.07.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
01.07.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
30.06.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
28.06.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
27.06.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
26.06.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
25.06.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
24.06.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
23.06.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
22.06.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
22.06.2021	The battle forming in the European fintech scene	This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. It’s no secret: Venture capitalists have grown bullish about Europe. In the first quarter of the ...
22.06.2021	The battle forming in the European fintech scene	This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Paid Content The true value of equity compensation From Personal Capital It’s no secret: Venture ...
21.06.2021	Lenz Therapeutics Raises $47M in Series A Financing	Lenz Therapeutics, a San Diego, CA-based biopharmaceutical company with a lead late clinical-stage program that represents a potential therapy for presbyopia, raised $47m in Series A funding. Backers included Versant Ventures and RA Capital...
21.06.2021	LENZ Therapeutics Raises $47M in Series A Funding to Further Develop Their Eye Drop Which Combats Vision Loss Due to Presbyopia	-
-	LENZ Therapeutics	-

LENZ Therapeutics

Investors 2

Funding Rounds 2

Mentions in press and media 88

Reviews 0